• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可能患有阿尔茨海默病的患者血清α1 -抗糜蛋白酶升高:一种无外周急性期反应的急性期反应物。

Increased serum alpha 1-antichymotrypsin in patients with probable Alzheimer's disease: an acute phase reactant without the peripheral acute phase response.

作者信息

Licastro F, Morini M C, Polazzi E, Davis L J

机构信息

Department of Experimental Pathology, University of Bologna, Italy.

出版信息

J Neuroimmunol. 1995 Mar;57(1-2):71-5. doi: 10.1016/0165-5728(94)00163-i.

DOI:10.1016/0165-5728(94)00163-i
PMID:7535791
Abstract

Serum levels of alpha 1-antichymotrypsin (alpha 1-ACT) were measured in patients with early and late onset Alzheimer's disease (e-AD, 1-AD), patients with vascular dementia (VD) and healthy elderly. Patients with 1-AD were divided into two groups, one had normal alpha 1-ACT values and one had increased serum levels of alpha 1-ACT. Other acute phase proteins were also measured. The serum levels of alpha 2-macroglobulin (alpha 2-MG), alpha 1-antitrypsin (alpha 1-AT), ceruloplasmin (CER), transferrin (TRSF) and alpha 1-acid glycoprotein (alpha 1-ac.GL) were within the normal range. The C reactive protein (CRP) was occasionally detectable at low concentrations in e-AD, in both groups of 1-AD patients and in VD patients. Low serum concentrations of interleukin-6 (IL-6) were found in a higher proportion of 1-AD than in patients with e-AD or VD. These results indicated that increased levels of alpha 1-ACT along with occasional detection of IL-6 might be peripheral markers of the 'acute reaction' in the brain.

摘要

在早发型和晚发型阿尔茨海默病患者(e-AD,1-AD)、血管性痴呆(VD)患者及健康老年人中检测了血清α1-抗糜蛋白酶(α1-ACT)水平。1-AD患者被分为两组,一组α1-ACT值正常,另一组血清α1-ACT水平升高。还检测了其他急性期蛋白。α2-巨球蛋白(α2-MG)、α1-抗胰蛋白酶(α1-AT)、铜蓝蛋白(CER)、转铁蛋白(TRSF)和α1-酸性糖蛋白(α1-ac.GL)的血清水平均在正常范围内。在e-AD患者、两组1-AD患者及VD患者中偶尔可检测到低浓度的C反应蛋白(CRP)。与e-AD或VD患者相比,1-AD患者中低血清浓度白细胞介素-6(IL-6)的比例更高。这些结果表明,α1-ACT水平升高以及偶尔检测到IL-6可能是大脑“急性反应”的外周标志物。

相似文献

1
Increased serum alpha 1-antichymotrypsin in patients with probable Alzheimer's disease: an acute phase reactant without the peripheral acute phase response.可能患有阿尔茨海默病的患者血清α1 -抗糜蛋白酶升高:一种无外周急性期反应的急性期反应物。
J Neuroimmunol. 1995 Mar;57(1-2):71-5. doi: 10.1016/0165-5728(94)00163-i.
2
Serological alpha 1-antichymotrypsin in patients with probable senile dementia of Alzheimer type: a short-term longitudinal study.阿尔茨海默型疑似老年痴呆患者的血清α1-抗糜蛋白酶:一项短期纵向研究。
Alzheimer Dis Assoc Disord. 1996 Winter;10(4):192-6. doi: 10.1097/00002093-199601040-00004.
3
Monomeric and polymeric forms of alpha-1 antichymotrypsin in sera from patients with probable late onset Alzheimer's disease.可能患有晚发性阿尔茨海默病患者血清中α-1抗糜蛋白酶的单体和聚合形式
Dement Geriatr Cogn Disord. 1997 Nov-Dec;8(6):337-42. doi: 10.1159/000106652.
4
Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?
J Neuroimmunol. 2000 Feb 1;103(1):97-102. doi: 10.1016/s0165-5728(99)00226-x.
5
Acute phase reactant alpha 1-antichymotrypsin is increased in cerebrospinal fluid and serum of patients with probable Alzheimer disease.
Alzheimer Dis Assoc Disord. 1995 Summer;9(2):112-8. doi: 10.1097/00002093-199509020-00009.
6
Blood levels of alpha-1-antichymotrypsin and risk factors for Alzheimer's disease: effects of gender and apolipoprotein E genotype.α-1-抗糜蛋白酶的血液水平与阿尔茨海默病的危险因素:性别和载脂蛋白E基因型的影响
Dement Geriatr Cogn Disord. 2000 Jan-Feb;11(1):25-8. doi: 10.1159/000017209.
7
Alpha 1-antichymotrypsin and IL-1 beta are not increased in CSF or serum in Alzheimer's disease.
Neurobiol Aging. 1994 May-Jun;15(3):313-7. doi: 10.1016/0197-4580(94)90026-4.
8
Elevated alpha 1-antichymotrypsin serum levels in a subset of nondemented first-degree relatives of Alzheimer's disease patients.阿尔茨海默病患者的一部分非痴呆一级亲属的血清α1-抗糜蛋白酶水平升高。
Dementia. 1995 Jan-Feb;6(1):17-20. doi: 10.1159/000106917.
9
Serum alpha 1-antichymotrypsin is not a useful marker for Alzheimer's disease or dementia in Parkinson's disease.血清α1-抗糜蛋白酶对帕金森病中的阿尔茨海默病或痴呆并非有用的标志物。
J Neural Transm Park Dis Dement Sect. 1993;6(2):145-9. doi: 10.1007/BF02261008.
10
Plasma and cerebrospinal fluid alpha1-antichymotrypsin levels in Alzheimer's disease: correlation with cognitive impairment.阿尔茨海默病患者血浆和脑脊液中α1-抗糜蛋白酶水平:与认知障碍的相关性
Ann Neurol. 2003 Jan;53(1):81-90. doi: 10.1002/ana.10414.

引用本文的文献

1
Study protocol for a randomised, double-blind, placebo-controlled 12-week pilot phase II trial of Sailuotong (SLT) for cognitive function in older adults with mild cognitive impairment.一项随机、双盲、安慰剂对照的为期 12 周的试验研究方案,旨在评估 Sailuotong(SLT)对轻度认知障碍老年人认知功能的影响。
Trials. 2018 Sep 25;19(1):522. doi: 10.1186/s13063-018-2912-0.
2
The 21st century epidemic: infections as inductors of neuro-degeneration associated with Alzheimer's Disease.21 世纪的流行病:感染作为阿尔茨海默病相关神经退行性变的诱导剂。
Immun Ageing. 2014 Dec 5;11(1):22. doi: 10.1186/s12979-014-0022-8. eCollection 2014.
3
Body fluid cytokine levels in mild cognitive impairment and Alzheimer's disease: a comparative overview.
轻度认知障碍和阿尔茨海默病患者的体液细胞因子水平:比较综述
Mol Neurobiol. 2014 Oct;50(2):534-44. doi: 10.1007/s12035-014-8657-1. Epub 2014 Feb 25.
4
Assessing candidate serum biomarkers for Alzheimer's disease: a longitudinal study.评估阿尔茨海默病的候选血清生物标志物:一项纵向研究。
J Alzheimers Dis. 2012;30(2):311-21. doi: 10.3233/JAD-2012-112012.
5
Blood-based protein biomarkers for diagnosis and classification of neurodegenerative diseases: current progress and clinical potential.用于神经退行性疾病诊断和分类的基于血液的蛋白质生物标志物:当前进展和临床潜力。
Mol Diagn Ther. 2011 Apr 1;15(2):83-102. doi: 10.1007/BF03256398.
6
Mediterranean diet, inflammatory and metabolic biomarkers, and risk of Alzheimer's disease.地中海饮食、炎症和代谢生物标志物与阿尔茨海默病风险。
J Alzheimers Dis. 2010;22(2):483-92. doi: 10.3233/JAD-2010-100897.
7
Biological marker candidates of Alzheimer's disease in blood, plasma, and serum.阿尔茨海默病在血液、血浆和血清中的生物标志物候选物。
CNS Neurosci Ther. 2009 Winter;15(4):358-74. doi: 10.1111/j.1755-5949.2009.00104.x. Epub 2009 Oct 14.
8
Inflammation as a potential mediator for the association between periodontal disease and Alzheimer's disease.炎症作为牙周病与阿尔茨海默病之间关联的潜在介质。
Neuropsychiatr Dis Treat. 2008 Oct;4(5):865-76. doi: 10.2147/ndt.s3610.
9
Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease.血浆和脑脊液中的肽和蛋白质作为阿尔茨海默病预测、诊断及治疗效果监测的生物标志物。
Biochim Biophys Acta. 2008 Oct;1782(10):549-58. doi: 10.1016/j.bbadis.2008.07.008. Epub 2008 Aug 7.